These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3260772)

  • 1. Heterogeneity of the response of venous smooth muscle to arterial endothelium-derived relaxing factor (EDRF) in respect of the role of nitric oxide.
    Vedernikov YP; Gräser T; Tiedt N; Vikhert AM
    Basic Res Cardiol; 1988; 83(2):122-7. PubMed ID: 3260772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation.
    Ignarro LJ; Byrns RE; Buga GM; Wood KS; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Jan; 244(1):181-9. PubMed ID: 2826766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-derived nitric oxide relaxes nonvascular smooth muscle.
    Buga GM; Gold ME; Wood KS; Chaudhuri G; Ignarro LJ
    Eur J Pharmacol; 1989 Feb; 161(1):61-72. PubMed ID: 2542037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endothelial relaxation factor as a local modulator of arterial function. The possibility of stabilization].
    Vedernikov IuP; Gräzer T; Osis IuG
    Fiziol Zh SSSR Im I M Sechenova; 1988 Feb; 74(2):153-61. PubMed ID: 3259514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-dependent hyperpolarization of canine coronary smooth muscle.
    Feletou M; Vanhoutte PM
    Br J Pharmacol; 1988 Mar; 93(3):515-24. PubMed ID: 2453240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.
    Ignarro LJ; Byrns RE; Buga GM; Wood KS
    Circ Res; 1987 Dec; 61(6):866-79. PubMed ID: 2890446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle.
    Ignarro LJ; Buga GM; Byrns RE; Wood KS; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Jul; 246(1):218-26. PubMed ID: 2839663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential selectivity of endothelium-derived relaxing factor and nitric oxide in smooth muscle.
    Shikano K; Ohlstein EH; Berkowitz BA
    Br J Pharmacol; 1987 Nov; 92(3):483-5. PubMed ID: 3501321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraluminally applied acetylcholine and oxyhemoglobin on the release and action of EDRF.
    Toda N; Minami Y; Onoue H
    Eur J Pharmacol; 1988 Jun; 151(1):123-6. PubMed ID: 3262068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium-free solution prevents the action but not the release of endothelium-derived relaxing factor.
    Rubanyi GM; Vanhoutte PM
    Eur J Pharmacol; 1988 Jan; 145(3):351-5. PubMed ID: 3258243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of relaxation responses of vascular and non-vascular smooth muscle to endothelium-derived relaxing factor (EDRF), acidified sodium nitrite (NO) and sodium nitroprusside.
    Cocks TM; Angus JA
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):364-72. PubMed ID: 2333103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of basal and acetylcholine-induced release of endothelium-derived relaxing factor on contraction to alpha-adrenoceptor agonists in a rabbit artery and corresponding veins.
    McGrath JC; Monaghan S; Templeton AG; Wilson VG
    Br J Pharmacol; 1990 Jan; 99(1):77-86. PubMed ID: 1970495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle.
    Shikano K; Berkowitz BA
    J Pharmacol Exp Ther; 1987 Oct; 243(1):55-60. PubMed ID: 3499504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
    Palmer RM; Ferrige AG; Moncada S
    Nature; 1987 Jun 11-17; 327(6122):524-6. PubMed ID: 3495737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelium-derived relaxing factor and nitroprusside compared in noradrenaline- and K+-contracted rabbit and rat aortae.
    Collins P; Henderson AH; Lang D; Lewis MJ
    J Physiol; 1988 Jun; 400():395-404. PubMed ID: 2843639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular reactivity to endothelium-derived relaxing factor in human umbilical artery at term pregnancy.
    Sugawara M; Tohse N; Nagashima M; Yabu H; Kudo R
    Can J Physiol Pharmacol; 1997 Jul; 75(7):818-24. PubMed ID: 9315349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of endothelium-dependent responses to acetylcholine in canine femoral arteries and veins. Separation of the role played by endothelial and smooth muscle cells.
    Rubanyi GM; Vanhoutte PM
    Blood Vessels; 1988; 25(2):75-81. PubMed ID: 3257889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anisodamine inhibits acetylcholine-induced endothelium-dependent relaxation of canine femoral artery.
    Guo HY; Loren RR; Vanhutte PM
    Chin Med J (Engl); 1992 Aug; 105(8):666-70. PubMed ID: 1458970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacology of EDRF and nitric oxide on vascular strips.
    Hutchinson PJ; Palmer RM; Moncada S
    Eur J Pharmacol; 1987 Sep; 141(3):445-51. PubMed ID: 3499329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxations to SIN-1, nitric oxide, and sodium nitroprusside in canine arteries and veins.
    Miller VM; Vanhoutte PM
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S67-71. PubMed ID: 2484703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.